Capstan Medical
Capstan Medical raises $110M Series C at $600M valuation
Capstan Medical: Series C Funding Round
Capstan Medical has successfully raised $110M in Series C funding, reaching a valuation of $600M.
Company Overview
Robotic minimally invasive heart valve technology
Funding Details
The Series C round was led by Eclipse Ventures, with participation from Cormorant Asset Management.
Company Information
- Headquarters: Campbell, CA
- Founded: 2018
- Employees: 90+
- Category: MedTech
Investment
Capstan Medical plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Eclipse Ventures: Verified investor in Series C
- Cormorant Asset Management: Verified investor in Series C
Company Info
Investors (2)
Share
Related Reports
Galvenize Therapeutics Raises $100M Series C to Transform MedTech
Galvenize Therapeutics has secured $100M Series C in funding to accelerate growth and innovation in the medtech sector. Medical device company developing pulsed electric field therapies for cardiac ablation and tumor treatment...
Reprieve Cardiovascular Raises $61M Series B to Transform MedTech
Reprieve Cardiovascular has secured $61M Series B in funding to accelerate growth and innovation in the medtech sector. Cardiovascular device company developing personalized heart failure therapies and monitoring solutions...
ViCentra Raises $85M Series D to Transform MedTech
ViCentra has secured $85M Series D in funding to accelerate growth and innovation in the medtech sector. Medical device company developing innovative insulin patch pumps for diabetes management...
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free